Unlocking AI’s True Potential in Drug Discovery: Why Ontologies Are the Semantic Foundation
Artificial intelligence is reshaping pharmaceutical R&D – from identifying novel therapeutic targets and predicting compound efficacy to accelerating clinical translation and enabling precision medicine. Yet, its impact is often limited by a familiar obstacle: fragmented, inconsistently annotated, and poorly structured scientific data scattered across legacy systems, lab notebooks, omics platforms, and clinical records. Without a reliable way to impose consistent meaning and relationships on this information, vast repositories of fragmented, inconsistently annotated, and poorly structured data make it difficult for AI models to generate reliable outputs or generalizable insights.
Ontologies solve this problem by providing the semantic backbone that connects human expertise with computational reasoning. They transform tacit scientific knowledge – assay definitions, phenotypes, targets, and endpoints – into explicit, machine-readable structures that support consistent interpretation, integration, and reasoning across the entire R&D pipeline.
Read More
